HOME › DRUGS › NINTEDANIB ESYLATE
ACTIVE SUBSTANCE / INN

NINTEDANIB ESYLATE

Brand name(s): OFEV, NINTEDANIB
FDA LISTED
PRESCRIPTION
NONE (TENTATIVE APPROVAL)
ANDA212555
NDA205832
ACTIVE SUBSTANCE
Nintedanib Esylate
REGULATORS
FDA
SPONSORS / MAH
GLENMARK PHARMS LTD, BOEHRINGER INGELHEIM
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OFEVNDA205832BOEHRINGER INGELHEIMPrescription
NINTEDANIBANDA212555GLENMARK PHARMS LTDNone (Tentative Approval)

FULL INTELLIGENCE ON NINTEDANIB ESYLATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →